Nike Names Pfizer’s Denton as Next CFO

Corroborated by 4 sources from 4 publishers

globalbusiness11h ago

TL;DR

Reports differ across sources; according to finance.yahoo.com, analyst Downgrade Highlights Near-Term Execution Risks The brokerage cited weakening sales trends, limited product innovation and growing concerns that Nike may need to lower market expectations ahead of a key investor event later this year.

Sources